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Editorial
The effect of UVB on lupus skin: new light on the
role of apoptosis in the pathogenesis of autoimmunity
Apoptosis is a major form of programmed cell death and occurs
in both physiological and pathological conditions. With apoptosis,
cells display distinct morphological and biochemical features that
allow their identiﬁcation and enumeration both in vivo and in vitro.
Prominent changes in cells undergoing this process are chromatin
condensation, DNA fragmentation, membrane blebbing and
externalization of phosphatidylserine of the cell membrane [1].
Once apoptosis is initiated, alterations in membrane structure
mark a cell for recognition by macrophages that can engulf the
dying cell for safe disposal. Indeed, the phagocytosis of dead cells
is one of the critical functions of the immune system in preventing
inadvertent immune activation by proinﬂammatory cellular
material arising during death. Given the potential impact of
dying cells and their products on the immune system, disturbances
of the cell death and clearance processes have been postulated to
occur in a variety of human diseases, including autoimmune
syndromes such as systemic lupus erythematosus (SLE).
In this issue of Rheumatology, Reefman and co-workers explore
possible abnormalities of cell death in SLE by investigating
the frequency of apoptotic cells in the skin resulting from exposure
of deﬁned areas to UVB light. Ultraviolet radiation, in particular
UVB with a short wavelength range (between 290 and 320 nm),
represents an important environmental factor that can trigger
a variety of deleterious responses in humans. The intracellular
processes induced by UVB are complex, cell injury and death being
mediated by various mechanisms, including DNA damage,
the production of reactive oxygen species and the activation of
cell death receptors [2]. In the skin, UVB is well characterized as
an inducer of cutaneous damage, causing the accumulation
of apoptotic keratinocytes at the dermo-epidermal junction.
Given the toxic products induced by UVB exposure, apoptosis
may represent part of a protective mechanism to remove damaged
cells and reduce the potential risk to the system from spillage of
their contents.
In SLE, the outcome of exposure to UVB radiation is
photosensitivity and the development of photolesions in the skin,
as observed typically in cutaneous lupus. The amount of energy
needed for UVB to provoke cutaneous changes is usually referred
to as the minimal erythemal dose (MED). Since photosensitivity
is one of the clinical hallmarks of lupus, it may not be surprising
that the SLE patients in the study of Reefman et al. had a lower
threshold than normal subjects for the development of an UVB-
induced erythema. This observation conﬁrms data from other
studies [3], although the ﬁnding that UVB-induced erythema can
be associated with an increased frequency of apoptotic cells
(detected by light microscopy or immunochemical staining for
cleaved caspase 3) is novel. Importantly, in the context of models
for the pathogenesis of SLE, it is notable that the number of
apoptotic cells and the amount of pycnotic nuclear debris observed
histologically in the skin of patients and healthy volunteers
were similar after 24 h. The development of erythema thus appears
to be directly linked to the number of apoptotic cells, but
the extent to which cells die appears to be independent of the
presence of underlying autoimmunity. These data thus suggest
that keratinocytes of SLE patients have normal sensitivity to
UVB-mediated apoptosis, at least under the conditions of the
present study.
Studies of several mouse models of SLE have suggested a
direct link between apoptosis and the development of lupus.
For example, defects involving the induction of apoptosis through
the Fas/FasL system [4], overexpression of the anti-apoptotic
molecule Bcl-2 [5] or heterozygosity for Pten (a tumour-suppressor
gene involved in the induction of apoptosis) [6] are all associated
with an increased number of autoreactive cells leading to
lymphoproliferation and autoimmunity. T and B lymphocytes
from these mice showed highly increased populations positive for
several activation markers as well as hypergammaglobulinaemia
with autoantibodies against nuclear antigens. Moreover, the
kidneys of these mice showed glomerular abnormalities due
to deposition of immune complexes. However, the effects of
UVB irradiation have not been extensively investigated in lupus
mouse models with respect to the induction of apoptosis [7] or the
potentiation of autoimmunity.
The evidence for disturbed apoptosis in human lupus, on the
other hand, is less clear. Increased levels of circulating apoptotic
cells have been found in SLE patients [8–10], although levels
did not correlate with disease activity in these studies. Data on
apoptotic keratinocytes in the skin lesions of SLE patients are
controversial with respect to both the induction of apoptosis
and correlation with autoantibodies [11–13]. These differences
could be due to the inﬂuence of various medication schemes or
differences in the patient population studied.
While Reefman et al. have shown a similarity in the frequency
of apoptotic cells in patients with SLE and normal subjects treated
with UVB, these ﬁndings do not exclude an important role of
defective apoptosis in the pathogenesis of lupus. Apoptosis is
a highly heterogeneous process that may vary in time-course
and biochemical features depending on cell type, location and
trigger. In the context of the current experiments, it is possible that
the number of apoptotic cells or the amount of nuclear debris
would differ between patients and controls at later time-points of
investigation. Similarly, it is possible that differences between
patients and normal subjects would be more pronounced if UVB
were applied repeatedly or in different concentrations over a
certain period instead of in one or two single doses. Moreover,
the duration of disease and activity of cutaneous lesions might
also inﬂuence the extent of apoptosis following UVB exposure.
The ﬁndings, while intriguing in terms of existing models for SLE,
must nevertheless be interpreted with caution, given the hetero-
geneity in the dynamics and mechanisms of cell death processes.
In addition to altered induction of apoptosis, the removal of
apoptotic cells has attracted interest in SLE as an important
element in the pathogenesis of the disease [14–17]. The clearance
of potentially autoantigenic material or debris created by dying
cells is a highly regulated process that may actively inhibit the
initiation of inﬂammation and immune responses. Cells under-
going apoptosis are removed rapidly through non-inﬂammatory
engulfment by macrophages or even non-professional phagocytes
such as ﬁbroblasts, endothelial cells, or vascular smooth muscle
cells [18]. The clearance process involves a host of cellular and
humoral elements to promote phagocytosis prior to the transition
of dying cells to secondary necrosis, a proinﬂammatory state,
or access of apoptotic cells to dendritic cells, where uptake would
lead to antigen presentation.
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Several defects are known in humans with respect to the
clearance of dying cells and cellular material. In the context
of SLE, in particular, relative failure of the acute-phase CRP
response [19], reduced activity of DNase I [20, 21] and complement
defects [22] could all contribute to impaired clearance of apoptotic
cells and the accumulation of cells in late apoptosis, a phase also
termed ‘secondary necrosis’. While the cellular events in the
late stages of the death processes are not well deﬁned, they may
involve leakage of proinﬂammatory molecules into the external
milieu; the generation of new moieties from proteolytic digestion
or the action of reactive oxygen species may also occur. A further
build-up of secondarily necrotic cells may occur when the
apoptotic load exceeds the local capacity for phagocytes to mediate
clearance, a situation that could reﬂect either increased death or
failed clearance. The time-course for these events is speculative
and it is possible that the experiments of Reefman et al. were
not long enough to detect defects in the phagocytosis of
apoptotic keratinocytes, a phenomenon that might explain
the increased rate of apoptotic cells in established skin lesions in
SLE patients.
More than 10 years ago, in seminal experiments Casciola-Rosen
et al. [23] showed that keratinocytes undergoing apoptosis after
exposure to UV light cluster a variety of macromolecules in blebs
on the cell surface. Importantly, these small blebs contained the
major autoantigens recognized by lupus sera. From these studies,
it can be hypothesized that the persistence of these blebs due to
impaired removal of apoptotic cells could lead to the release of
antigenic structures into the surrounding tissue or circulation.
Once released, these structures might induce an immune response
culminating in the production of autoantibodies. In their study,
Reefman and co-workers did not ﬁnd a correlation between MED
values and the presence of autoantibodies in the serum. Other
investigators, however, have shown such a correlation [13],
in particular by showing a positive association between anti-Ro
(SS-A)/anti-La (SS-B) autoantibodies and a pathological photo-
provocation. This issue awaits further experimentation under other
conditions.
While the study of Reefman et al. did not show increased
apoptosis following UVB exposure in patients with SLE, it is
nevertheless important in providing an in vivo test for an
important hypothesis. However, these ﬁndings must be viewed
tentatively, given the complexity of the death process and the
multitude of ways in which cells can succumb. Sunlight
remains hazardous to patients and it is still too early to conclude
that UVB-induced apoptosis in SLE is intact and that UVB does
not play a role in inducing cell death and injury that provokes
autoreactivity.
The skin is a unique system for study since it is a very accessible
site and allows experiments not possible with other organs. It will
be a challenge to investigators to devise experimental systems to
assess death processes in tissues that cannot be readily biopsied or
followed after exposure to agents that are too toxic for systemic
administration. While the studies of Reefman et al. shed some light
on an important subject, they provide a reminder that, like life,
death is a complicated process and its role in SLE still appears to be
not well understood.
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